Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 528)
Antimicrobial Activity of Synthetic Human CAP18 Peptides to Streptococcus sanguis Isolated from Patients with Behçeťs Disease
KeywordsMinimal Inhibitory Concentration Antimicrobial Peptide Kawasaki Disease Analog Peptide Peptide Antibiotic
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- 4.Srensen, O.E., Follin, P., Johnsen, A. H., et al., 2001, Human cathelicidin, hCAP18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with protease 3. Blood 97: 3951–3959.Google Scholar
- 8.Yang, D., Chen, Q., Schmidt, A.P., et al., 2000, LL-37, the neutrophil granule and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192: 1069–1074.PubMedGoogle Scholar
- Frohm Nilsson, M., Agerberth, B., Ahangari, G., et al., 1997, The expression of the gene coding for the antimicrobial peptide LL-37 is induced human keratinocytes during inflammatory disorders. J. Biol. Chem. 272: 15258–15263.Google Scholar
- 12.Mizushima, Y. (The Behçeťs disease Research Committee of Japan), 1989, Skin hypersensitivity to Streptococcus sanguis and the induction of symptoms by the antigens in Behçeťs disease — A multicenter study. J. Rheumatol. 16: 506–511.Google Scholar
© Kluwer Academic Publishers 2004